Randi J. Hagerman, MD
- 5Articles
- 18.4KReads1
- 2006–2014Active
- 34Collaborators
- 242Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Randi J. Hagerman, MD, has published extensively on Fragile X syndrome and related premutation disorders, focusing on their molecular basis, neurological manifestations, and psychiatric phenotypes. The work includes clinical trials assessing treatments such as memantine for Fragile X-associated tremor/ataxia syndrome and reviews expanding the psychiatric understanding of these genetic conditions. Hagerman’s research spans rare diseases, neurology, genetics, mood disorders, and psychiatry, contributing to the translation of molecular advances into therapeutic approaches.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
